发明名称 Compositions and methods related to miRNA modulation of neovascularization or angiogenesis
摘要 The present invention concerns methods and compositions for diagnosing and/or treating vascular diseases including cancer, cardiac diseases, vascular diseases of the eye, and inflammatory diseases. The methods involve measuring the levels of one or multiple miRNAs in patient samples and using the test results to diagnose and/or predict an optimal treatment regimen for the patient. Compositions described in the invention include nucleic acids that function as miRNAs or miRNA inhibitors that can be introduced to a patient to reduce or increase vascularization as needed.
申请公布号 US9540645(B2) 申请公布日期 2017.01.10
申请号 US201615132874 申请日期 2016.04.19
申请人 The John Hopkins University;ASURAGEN, Inc. 发明人 Shen Jikui;Kelnar Kevin;Shelton Jeffrey;Brown David;Campochiaro Peter
分类号 C07H21/02;C07H21/04;A61K48/00;C12N15/113;C12Q1/68 主分类号 C07H21/02
代理机构 Wilson Sonsini Goodrich & Rosati 代理人 Wilson Sonsini Goodrich & Rosati
主权项 1. A method for reducing unwanted neovascularization in an individual in need thereof comprising administering to the individual a therapeutically-effective amount of an inhibitor of miR-122a-comprising a single-stranded oligonucleotide that is complementary to a sequence of mature miR-122a (SEQ ID NO: 92).
地址 Baltimore MD US